{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:27:37Z","timestamp":1782970057731,"version":"3.54.5"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajpc.2025.101353","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:32:45Z","timestamp":1763649165000},"page":"101353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nonlinear association between glycemic markers and incident cardio\u2011renal\u2011metabolic multimorbidity: two decades of follow\u2011up in the Tehran Lipid and Glucose Study"],"prefix":"10.1016","volume":"24","author":[{"given":"Navid","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Masrouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Saeed Tamehri","family":"Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Tohidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0352-8666","authenticated-orcid":false,"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2019.11.046","article-title":"Cardiometabolic-based chronic disease, addressing knowledge and clinical practice gaps: JACC State-of-the-art review","volume":"75","author":"Mechanick","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0003","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","author":"Laakso","year":"2014","journal-title":"Nat rev endocrinol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0004","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1136\/bmj.p2327","article-title":"Multiple long term conditions, multimorbidity, and co-morbidities: we should reconsider the terminology we use","volume":"383","author":"Khunti","year":"2023","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101353_bib0005","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"20","key":"10.1016\/j.ajpc.2025.101353_bib0006","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101353_bib0007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","article-title":"Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020","volume":"8","author":"Ostrominski","year":"2023","journal-title":"JAMA cardiol"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101353_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024476","article-title":"Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study","volume":"9","author":"Zhang","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101353_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/2235042X20961919","article-title":"Multimorbidity of chronic non-communicable diseases in low- and middle-income countries: a scoping review","volume":"10","author":"Abebe","year":"2020","journal-title":"J Comorb"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049133","article-title":"Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Asogwa","year":"2022","journal-title":"BMJ open"},{"issue":"10397","key":"10.1016\/j.ajpc.2025.101353_bib0013","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101353_bib0014","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/dc22-2376","article-title":"Global prevalence of prediabetes","volume":"46","author":"Rooney","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101353_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc18-1773","article-title":"Long-term absolute risk for cardiovascular disease stratified by fasting glucose level","volume":"42","author":"Bancks","year":"2019","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101353_bib0016","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1210\/jc.2019-00073","article-title":"Impaired fasting glucose and chronic kidney disease, albuminuria, or worsening kidney function: a secondary analysis of SPRINT","volume":"104","author":"Bigotte Vieira","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ajpc.2025.101353_bib0017","doi-asserted-by":"crossref","first-page":"m2297","DOI":"10.1136\/bmj.m2297","article-title":"Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101353_bib0018","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/dme.13113","article-title":"Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis","volume":"33","author":"Echouffo-Tcheugui","year":"2016","journal-title":"Diabet Med"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101353_bib0019","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4158\/PS-2018-0139","article-title":"Dysglycemia-based chronic disease: an American Association of Clinical Endocrinologists position Statement","volume":"24","author":"Mechanick","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajpc.2025.101353_bib0020","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","article-title":"Prediabetes and the risk of cancer: a meta-analysis","volume":"57","author":"Huang","year":"2014","journal-title":"Diabetologia"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101353_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052036","article-title":"Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis","volume":"7","author":"Gast","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ajpc.2025.101353_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2016.11.009","article-title":"Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis","volume":"464","author":"Wang","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpc.2025.101353_bib0023","article-title":"Association of impaired fasting glucose with cardiometabolic multimorbidity: the Kailuan study","author":"Guo","year":"2024","journal-title":"J Diabetes Investig"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0024","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12916-024-03749-6","article-title":"Influence of impaired glucose tolerance and type 2 diabetes on the multimorbidity cluster of cardiovascular disease and cancer: a post hoc analysis of the da qing diabetes prevention outcome study","volume":"22","author":"Chen","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.ajpc.2025.101353_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1018403","article-title":"Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: over a decade of follow-up in the Tehran lipid and glucose study","volume":"9","author":"Asgari","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101353_bib0026","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/2047487319834396","article-title":"Sex-specific clinical outcomes of impaired glucose status: a long follow-up from the Tehran Lipid and Glucose Study","volume":"26","author":"Parizadeh","year":"2020","journal-title":"Eur J Prev Cardiol"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101353_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/BF03346527","article-title":"Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the tehran lipid and glucose study (TLGS)","volume":"32","author":"Hadaegh","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101353_bib0028","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00592-018-1195-y","article-title":"Fasting plasma glucose is a stronger predictor of diabetes than triglyceride\u2013glucose index, triglycerides\/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance: tehran lipid and glucose study","volume":"55","author":"Tohidi","year":"2018","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0029","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-6215-10-5","article-title":"Prevention of non-communicable disease in a population in nutrition transition: tehran lipid and glucose study phase II","volume":"10","author":"Azizi","year":"2009","journal-title":"Trials"},{"issue":"19","key":"10.1016\/j.ajpc.2025.101353_bib0030","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine-and cystatin C\u2013based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00592-011-0298-5","article-title":"Fasting glucose cutoff point: where does the risk terminate? Tehran lipid and glucose study","volume":"49","author":"Bozorgmanesh","year":"2012","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0032","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/eurpub\/ckq074","article-title":"A simple risk score effectively predicted type 2 diabetes in Iranian adult population: population-based cohort study","volume":"21","author":"Bozorgmanesh","year":"2011","journal-title":"Eur J Public Health"},{"issue":"3","key":"10.1016\/j.ajpc.2025.101353_bib0033","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jamainternmed.2017.7978","article-title":"Lactation duration and progression to diabetes in women across the childbearing years: the 30-year CARDIA study","volume":"178","author":"Gunderson","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101353_bib0034","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00125-016-3969-5","article-title":"Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study","volume":"59","author":"Chow","year":"2016","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101353_bib0035","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.clnu.2024.06.006","article-title":"Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study","volume":"43","author":"Belsti","year":"2024","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0036","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00592-015-0730-3","article-title":"Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: tehran Lipid and Glucose Study","volume":"52","author":"Ghasemi","year":"2015","journal-title":"Acta Diabetol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101353_bib0037","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpc.2025.101353_bib0038","doi-asserted-by":"crossref","unstructured":"National cholesterol education program. Expert panel on D, treatment of high blood cholesterol in A. Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): the Program; 2002.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"24","key":"10.1016\/j.ajpc.2025.101353_bib0039","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.ajpc.2025.101353_bib0040","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/ajh\/hpz105","article-title":"Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events","volume":"32","author":"Rathi","year":"2019","journal-title":"Am J Hypertens"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101353_bib0041","doi-asserted-by":"crossref","first-page":"375","DOI":"10.7326\/M16-2966","article-title":"Effects of intensive systolic blood pressure control on kidney and cardiovascular outcomes in persons without kidney disease: a secondary analysis of a randomized trial","volume":"167","author":"Beddhu","year":"2017","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101353_bib0042","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"lancet Diabetes endocrinol"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/j.ajkd.2014.11.009","article-title":"Change in novel filtration markers and risk of ESRD","volume":"66","author":"Rebholz","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101353_bib0044","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2215\/CJN.09770915","article-title":"Progression of kidney disease in indigenous Australians: the eGFR follow-up study","volume":"11","author":"Maple-Brown","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4 Suppl","key":"10.1016\/j.ajpc.2025.101353_bib0045","article-title":"Outcomes of a longitudinal population-based cohort study and pragmatic community trial: findings from 20 years of the Tehran lipid and glucose study","volume":"16","author":"Khalili","year":"2018","journal-title":"Int J Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ajpc.2025.101353_bib0046","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1016\/S2468-2667(21)00107-9","article-title":"Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies","volume":"6","author":"Ho","year":"2021","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0047","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12933-024-02347-3","article-title":"Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.163406","article-title":"Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: a national prospective cohort","volume":"881","author":"Wu","year":"2023","journal-title":"Sci Total Environ"},{"issue":"446","key":"10.1016\/j.ajpc.2025.101353_bib0049","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101353_bib0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/j.ajpc.2025.101353_bib0051","series-title":"Multiple imputation. flexible imputation of missing data","first-page":"29","author":"Rubin","year":"2018"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-016-0277-1","article-title":"Clinical prediction in defined populations: a simulation study investigating when and how to aggregate existing models","volume":"17","author":"Martin","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0053","first-page":"1","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0054","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001776","article-title":"Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis","volume":"9","author":"Gujral","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Supplement_1","key":"10.1016\/j.ajpc.2025.101353_bib0055","first-page":"S27","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes\u20142025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0056","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2024-001539","article-title":"Association of pre-diabetes with the risks of adverse health outcomes and complex multimorbidity: evidence from population-based studies in the NIS and UK Biobank","volume":"3","author":"Wu","year":"2025","journal-title":"BMJ Public Health"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101353_bib0057","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ijcard.2012.04.053","article-title":"Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study","volume":"167","author":"Yadegari","year":"2013","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.ajpc.2025.101353_bib0058","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/dc12-1577","article-title":"Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases","volume":"36","author":"Park","year":"2013","journal-title":"Diabetes Care"},{"issue":"9733","key":"10.1016\/j.ajpc.2025.101353_bib0059","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajpc.2025.101353_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000955","article-title":"Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China","volume":"8","author":"Li","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101353_bib0061","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/dc10-2263","article-title":"Normal fasting plasma glucose and risk of type 2 diabetes","volume":"34","author":"Brambilla","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.ajpc.2025.101353_bib0062","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2337\/dc21-2521","article-title":"Association of longitudinal trajectories of insulin resistance with adverse renal outcomes","volume":"45","author":"Yang","year":"2022","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101353_bib0063","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1016\/j.ijcard.2013.05.038","article-title":"Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study","volume":"168","author":"Deedwania","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ajpc.2025.101353_bib0064","doi-asserted-by":"crossref","first-page":"afac109","DOI":"10.1093\/ageing\/afac109","article-title":"Long-term risks for cardiovascular disease and mortality across the glycaemic spectrum in a male-predominant Chinese cohort aged 75 years or older: the Kailuan study","volume":"51","author":"Liu","year":"2022","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.ajpc.2025.101353_bib0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2337\/dc19-1221","article-title":"Mortality implications of prediabetes and diabetes in older adults","volume":"43","author":"Tang","year":"2020","journal-title":"Diabetes care"},{"issue":"11","key":"10.1016\/j.ajpc.2025.101353_bib0066","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","article-title":"Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020","volume":"8","author":"Ostrominski","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2025.101353_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International diabetes federation diabetes Atlas, 9(th) edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pr"},{"issue":"4","key":"10.1016\/j.ajpc.2025.101353_bib0068","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.ijcard.2012.04.053","article-title":"Non-linear contribution of glucose measures to cardiovascular diseases and mortality: reclassifying the Framingham's risk categories: a decade follow-up from the Tehran lipid and glucose study","volume":"167","author":"Yadegari","year":"2013","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2025.101353_bib0069","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/2047487319834396","article-title":"Sex-specific clinical outcomes of impaired glucose status: a long follow-up from the tehran lipid and glucose study","volume":"26","author":"Parizadeh","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"1 Suppl 1","key":"10.1016\/j.ajpc.2025.101353_bib0070","first-page":"S27","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.ajpc.2025.101353_bib0071","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045304","article-title":"Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort","volume":"7","author":"Tohidi","year":"2012","journal-title":"PLoS One"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667725004283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T09:47:14Z","timestamp":1765446434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667725004283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":70,"alternative-id":["S2666667725004283"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101353","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonlinear association between glycemic markers and incident cardio\u2011renal\u2011metabolic multimorbidity: two decades of follow\u2011up in the Tehran Lipid and Glucose Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2025.101353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101353"}}